IODOFLEX

This brand name is authorized in New Zealand.

Active ingredients

The drug IODOFLEX contains one active pharmaceutical ingredient (API):

1	Cadexomer iodine
	In contact with wound exudate cadexomer iodine absorbs fluid, removes exudate, pus and debris from the wound surface. Iodine is physically immobilised within the matrix of the dry cadexomer iodine and is slowly released in an active form during uptake of wound fluid. This mechanism of release provides antibacterial activity both at the wound surface and within the formed gel.
	Read more about Cadexomer iodine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
IODOFLEX Impregnated dressing	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D03AX01	Cadexomer iodine	D Dermatologicals → D03 Preparations for treatment of wounds and ulcers → D03A Cicatrizants → D03AX Other cicatrizants
Discover more medicines within D03AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NZ	Medicines and Medical Devices Safety Authority	8113